Request Sample Inquiry
Naloxone Market

Naloxone Market

Naloxone Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

Base Year:



Sep - 2023



Report Code:


Segments Covered
  • By Route of Administration By Route of Administration Injectables, Nasal, Oral
  • By Strength By Strength 0.02mg/ml, 1mg/ml, 0.4mg/ml, Others
  • By Distribution channel By Distribution channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1119.6 Million
Revenue 2030Revenue 2030: USD 2617.6 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 11.2%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Naloxone Market Share

The global Naloxone Market is valued at USD 1119.6 Million in 2022 and is projected to reach a value of USD 2617.6 Million by 2030 at a CAGR (Compound Annual Growth Rate) of 11.2% between 2023 and 2030.

Premium Insights

According to the UNODC World Drug Report, there are 35 million opioid users worldwide, which is significantly impacting the demand for naloxone. Opioids, which account for 70% of drug-related illnesses and fatalities, highlight the importance of having widespread access to naloxone. For instance, the Division of Substance Abuse and Mental Health's (DSAMH) provide free monthly naloxone training in Delaware. In addition to giving locals the knowledge they need to recognize and deal with opioid overdoses; this training also reflects the understanding that usage of naloxone is a crucial for saving lives and lessening the destructive effects of opiate abuse on communities.

Naloxone Market Size, 2022 To 2030 (USD Million)

AI (GPT) is here !!! Ask questions about Naloxone Market

  • The Novel naloxone administration techniques, like nasal sprays and auto-injectors, have been developed, boosting usability and accessibility leading the market for Naloxone
  • North America generated more than 41.25% of revenue share in 2022
  • Asia Pacific is expected to grow at the quickest rate from 2023 to 2030
  • Nasal segment accounted for the largest market growth. It contributed over 42.5% of the total revenue share in 2022 due to its ease of use and rapid administration, making it the preferred choice for opioid overdose reversal
  • 1mg/ml segment revealed the most significant market growth, contributing more than 37.8% of the total revenue share in 2022
  • Hospital Pharmacies segment will account for 38.5% of total market share in 2022

Top Market Trends

  • The market for naloxone is significantly influenced by the global opioid addiction and overdose issue. The need for naloxone to stop overdoses is increasing as the number of opioid-related fatalities rises.
  • Nasal sprays, injectables, and auto-injectors are just a few of the different ways that naloxone is becoming more widely accessible. As a result, it is simpler for people to obtain naloxone and utilize it to stop an opioid overdose.
  • The significance of naloxone for opioid overdose reversal is becoming more well recognized. Governmental and healthcare groups are driving this with their initiatives and educational campaigns.
  • New naloxone formulations, including long-acting naloxone and naloxone implants, are currently being developed. Naloxone may become more usable and effective thanks to these new formulations.
  • Governments all throughout the world are putting plans in place to encourage the use of naloxone. These programs include lowering the cost and increasing the availability of naloxone as well as offering naloxone use instruction.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

Economic Insights

The alarming surge in opioid overdose instances, which have increased by 30% over the past ten years, is to reason for the growth of Naloxone market. Pharmaceutical firms responded by releasing a wide variety of naloxone medicines, helping to create a market worth over USD 2 billion. The cost of naloxone, which affects accessibility, can range from USD 20 to USD 100 each dose, thus worries regarding affordability still exist. Government measures to address this issue have increased access to naloxone through public health programs by 50% by making it free or at significantly reduced cost. For instance, in July 2022, to implement the THN take home naloxone program nationally, the Australian government will invest $19.6 million over the course of four years beginning in 2022–2023. A program that provides free naloxone to anyone who could see or experience an opioid overdose.

Market Segmentation

Naloxone The global Naloxone market can be categorized into Route of Administration, Strength, Distribution channel, Region. The Naloxone market can be categorized into Injectables, Nasal, Oral based on Route of Administration. The Naloxone market can be categorized into 0.02mg/ml, 1mg/ml, 0.4mg/ml, Others based on Strength. The Naloxone market can be categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others based on Distribution channel. The Naloxone market can be categorized into North America, Europe, Asia Pacific, Latin America, Middle East & Africa based on Region.

Based on Route of Administration

Nasal holds the largest share

The Naloxone market is expected to be dominated by the nasal segment because of its user-friendliness leading to adoption among consumers. It can be easily delivered by people without medical training, doing away with the necessity for injections or needles. Furthermore, nasal naloxone is a recommended option for handling this serious medical emergency because of its quick action, which enables the quick reversal of opioid overdoses, frequently within minutes.

Based on Strength

1mg/ml will account for largest market share

The 1 mg/ml segment's dominance in the Naloxone market is largely due to it is the most generally available strength of naloxone for opioid overdose reversal because it is the most frequent available amount. The ability to reverse opioid overdoses, even those involving high opioid dosages, further emphasizes its critical role in lifesaving. Its adaptability in forms including nasal sprays, injectables, and auto-injectors also contributes to its appeal by meeting a variety of market administration preferences and emergency scenarios.

Based on Distribution Channel

Hospital Pharmacies dominated the market

Since, naloxone for opioid overdose reversal is primarily obtained through hospitals, the hospital pharmacies segment is anticipated to dominate the market. Hospitals are also well-positioned to provide thorough naloxone delivery training to both their medical personnel and patients, supporting their crucial role in handling opioid overdose emergencies.

Based on Region

North America will lead the market

North America is expected to dominate the market for Naloxone due to the high rate of opioid overdoses in the area highlights the urgent need for naloxone as a life-saving treatment. The importance of naloxone in reversing opioid overdoses is also becoming increasingly recognized, which is accelerating its uptake. The region's high incidence of naloxone is largely a result of government programs to encourage its use. Additionally, the fact that naloxone is offered in a variety of dosage forms, such as nasal sprays, injectables, and auto-injectors, improves accessibility and usability and solidifies North America's position as the market leader for naloxone.

Competitive Landscape

The global Naloxone market is fragmented, including a diverse array of the presence of several key players, healthcare providers, and government agencies striving to address the opioid overdose crisis. Government initiatives and policies aimed at expanding naloxone access, coupled with advocacy groups and community-based organizations, create a multifaceted competitive environment aimed at increasing the availability and utilization of naloxone to combat opioid overdoses.

The players in the global Naloxone market include Pfizer,West Ward Pharmaceuticals,Amneal Pharmaceuticals,Sandoz,ADAPT Pharma,Mylan,kaleo,Amphastar Pharmaceuticals among others.

Recent Market Developments

March 2023: The U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription, use – the first naloxone product approved for use without a prescription.

January 2023: The prefilled syringe (PFS) form of Naloxone Hydrochloride Injection, USP, 2mg/2mL has been introduced, according to Hikma Pharmaceuticals PLC (Hikma), a global pharmaceutical firm. The third PFS medication to be released, the drug is indicated for the immediate treatment of an opioid overdose that is either known or suspected.

Segmentation of the Global Naloxone Market

Parameter Details
Segments Covered

By Route of Administration

  • Injectables
  • Nasal
  • Oral

By Strength

  • 0.02mg/ml
  • 1mg/ml
  • 0.4mg/ml
  • Others

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Pfizer
  • West Ward Pharmaceuticals
  • Amneal Pharmaceuticals
  • Sandoz
  • ADAPT Pharma
  • Mylan
  • kaleo
  • Amphastar Pharmaceuticals
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Frequently Asked Question
  • The global Naloxone valued at USD 1119.6 Million in 2022 and is expected to reach USD 2617.6 Million in 2030 growing at a CAGR of 11.2%.

  • The prominent players in the market are Pfizer,West Ward Pharmaceuticals,Amneal Pharmaceuticals,Sandoz,ADAPT Pharma,Mylan,kaleo,Amphastar Pharmaceuticals.

  • The market is project to grow at a CAGR of 11.2% between 2023 and 2030.

  • The driving factors of the Naloxone include

  • North America was the leading regional segment of the Naloxone in 2022.